NLRP3 and atherosclerosis: Reduced lanosterol levels in mice transgenically overexpressing 3β-hydroxysterol Δ24-reductase (DHCR24), further correlated with progression of atherosclerosis, as well as with enhanced type I IFN responses and NLRP3-dependent inflammasome activation (Zhang et al., 2021).